Francois Rochon - Giverny Capital
Holding/activity history for  Edwards Lifesciences Corp. (EW)
Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
2024   Q3 | 446,288 | 1.12 | Add 0.06% | 0.00 | $65.99 |
2024   Q2 | 446,016 | 1.74 | Add 0.07% | 0.00 | $92.37 |
2024   Q1 | 445,718 | 1.73 | Add 1.09% | 0.02 | $95.56 |
2023   Q4 | 440,906 | 1.58 | Add 0.07% | 0.00 | $76.25 |
2023   Q3 | 440,602 | 1.66 | Add 0.16% | 0.00 | $69.28 |
2023   Q2 | 439,896 | 2.18 | Add 6.01% | 0.12 | $94.33 |
2023   Q1 | 414,975 | 2.07 | Reduce 2.63% | 0.06 | $82.73 |
2022   Q4 | 426,173 | 1.97 | Reduce 0.94% | 0.02 | $74.61 |
2022   Q3 | 430,196 | 2.41 | Add 3.19% | 0.07 | $82.63 |
2022   Q2 | 416,882 | 2.61 | Add 2.91% | 0.07 | $95.09 |
2022   Q1 | 405,091 | 2.69 | Reduce 0.17% | 0.00 | $117.72 |
2021   Q4 | 405,762 | 2.80 | Add 0.90% | 0.02 | $129.55 |
2021   Q3 | 402,150 | 2.71 | Reduce 0.83% | 0.02 | $113.21 |
2021   Q2 | 405,529 | 2.55 | Add 3.94% | 0.10 | $103.57 |
2021   Q1 | 390,140 | 2.18 | Add 0.60% | 0.01 | $83.64 |
2020   Q4 | 387,814 | 2.71 | Add 3.85% | 0.10 | $91.23 |
2020   Q3 | 373,422 | 2.73 | Add 0.21% | 0.01 | $79.82 |
2020   Q2 | 372,627 | 2.56 | Add 214.65% | 1.75 | $69.11 |
2020   Q1 | 118,426 | 2.84 | Reduce 7.85% | 0.24 | $188.62 |
2019   Q4 | 128,515 | 2.71 | Add 1.01% | 0.03 | $233.29 |
2019   Q3 | 127,233 | 2.79 | Add 0.19% | 0.01 | $219.91 |
2019   Q2 | 126,990 | 2.37 | Add 2.47% | 0.06 | $184.74 |
2019   Q1 | 123,923 | 2.72 | Add 1.43% | 0.04 | $191.33 |
2018   Q4 | 122,178 | 2.47 | Reduce 32.38% | 1.18 | $153.17 |
2018   Q3 | 180,690 | 3.56 | Add 4.74% | 0.16 | $174.10 |
2018   Q2 | 172,508 | 3.27 | Add 0.78% | 0.03 | $145.57 |
2018   Q1 | 171,166 | 3.20 | Add 5.94% | 0.18 | $139.52 |
2017   Q4 | 161,571 | 2.50 | $112.71 |